HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Tuesday, 2 June 2015

Recently published CEAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. From the ones listed this time, here's a few in our areas of research interest:

Becerra V, Gracia A, Desai K, et. al. Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK. BMJ Open. 2015 May 9;5(5):e007111. PubMed PMID: 25991449.

Valente M, Cortesi PA, Lassandro G, et. al. Health economic models in hemophilia A and utility assumptions from a clinician's perspective. Pediatr Blood Cancer. 2015 May 14. [Epub ahead of print] PubMed PMID: 25976056.

Roze S, Smith-Palmer J, Valentine W, et. al. Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review. Diabet Med. 2015 May 11. [Epub ahead of print] PubMed PMID: 25962621.

Isaranuwatchai W, Markle-Reid M, Hoch JS. Adjusting for Baseline Covariates in Net Benefit Regression: How You Adjust Matters. Pharmacoeconomics. 2015 May 10. [Epub ahead of print] PubMed PMID: 25957531.